PORTAL and OneFlorida: ‘Safety of Direct Acting Antivirals for Patients with Hepatitis C Virus’ Adverse Events Definitions
Categories: Data Capture, Integration, and Linkage
The ‘Safety of Direct Acting Antivirals (DAA) for Patients with Hepatitis C Virus (HCV)’ project examined whether patients with HCV who are prescribed newer DAA medications experienced higher rates of adverse events than patients with HCV who are untreated. The project team is sharing the list of the adverse events and definitions (e.g., ICD-9 and ICD-10 codes) used in this study of the safety of a specific medication. It can be used by others who are studying these types of adverse events.
Published: October 16, 2018
Author: Jason Kramer